NASDAQ · Biotechnology

PRLD (PRLD) Stock

$4.52 +2.96% NASDAQ: PRLD Healthcare

Valuation

MetricValue
Price$4.52
Market Cap$257.34M
P/E Ratio-3.27
P/B Ratio3.41
P/S Ratio14.53
EPS (TTM)$-1.29
52-Week High$5.66
52-Week Low$0.75
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-143.48%
ROA-70.21%
ROCE-154.41%
Gross Margin-875.00%
Operating Margin-875.00%
Net Margin-4.65%
Debt/Equity0.29
Current Ratio2.00

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$7.0M$12.0M
Operating Profit$-114.0M$-124.0M$-132.0M$-140.0M$-105.0M
Net Profit$-112.0M$-115.0M$-122.0M$-127.0M$-99.0M
EPS$-2.33$-2.27$-2.02$-1.68$-1.29
Op Margin———-1995.9%-861.3%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$305.0M$221.0M$278.0M$176.0M$141.0M
Total Liabilities$19.0M$25.0M$41.0M$44.0M$73.0M
Cash$32.0M$31.0M$25.0M$12.0M$35.0M
Borrowings$2.0M$2.0M$17.0M$18.0M$18.0M

Latest News

Prelude Therapeutics (PRLD) Upgraded to Buy: Here's Why Zacks · Jul 17, 2026 Goldman Sachs Initiates Coverage of Prelude Therapeutics (PRLD) Insider Monkey · May 31, 2026 Earnings Beat: Prelude Therapeutics Incorporated (NASDAQ:PRLD) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts Simply Wall St. · May 16, 2026 Prelude Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update GlobeNewswire · May 12, 2026 Wall Street Analysts Think Prelude Therapeutics (PRLD) Could Surge 33.59%: Read This Before Placing a Bet Zacks · May 8, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-84.0M$-84.0M$-107.0M$-103.0M$-56.0M
Investing Cash Flow$-266.0M$79.0M$-38.0M$89.0M$53.0M
Financing Cash Flow$3.0M$1.0M$1.0M$0$0
Net Cash Flow$-182.0M$-1.0M$-5.0M$-13.0M$22.0M
Free Cash Flow$-86.0M$-87.0M$-111.0M$-104.0M$-56.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-18.02%
Quick Ratio2.03
Interest Coverage—
Return 1Y331.87%
Return 3Y-14.19%
Return 5Y-84.33%

Ownership

Insiders Held13.80%
Institutions Held64.81%
Institutions Float Held75.18%
Institutional HolderSharesReport Date
Orbimed Advisors LLC.16,589,4422026-03-31
Baker Bros. Advisors, LP10,123,8242026-03-31
Kynam Capital Management, LP1,592,5512026-03-31
Vanguard Capital Management LLC1,230,4062026-03-31
EcoR1 Capital, LLC947,0492026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AVTX $18.97 +2.87% -2.79 $214.25M 0.00%
CRBU $1.65 +0.61% -1.25 $163.65M 0.00%
ENTA $12.61 -0.94% -6.04 $366.68M 0.00%
EPRX $6.05 +4.13% -5.99 $202.55M 0.00%
FHTXFoghorn Therapeutics Inc. $5.20 +7.22% -4.15 $305.31M 0.00%

About PRLD

PRLD is led by CEO Krishna Vaddi, employs 131 people, headquartered in US, publicly traded since 2020.

PRLD stock trades at $4.52 with a market capitalization of $257.34M. The stock is valued at a price-to-earnings (P/E) ratio of -3.27, price-to-book of 3.41, price-to-sales of 14.53. Over the past 52 weeks the stock has ranged between $0.75 and $5.66, and currently trades 20.1% below its 52-week high.

On profitability, PRLD generates a return on equity (ROE) of -143.48%, return on capital employed of -154.41%, an operating margin of -875.00%, a net profit margin of -4.65%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides